The abstract is read at the publisher; the summary is JClub's.
Doubling early-pregnancy serum PFDoA in 2,984 women in Henan Province, China (2018–2021) is linked to higher odds of gestational hypertension and preeclampsia.
- Why it matters: Evidence on PFAS and hypertensive disorders of pregnancy has been inconsistent, and it is unclear whether specific PFAS congeners or fetal sex change these associations.
- What they did: The study measured 16 PFAS in early pregnancy serum and analyzed nine with detection rates ≥70% using multivariable logistic regression, plus quantile g-computation for mixture effects.
- The result: PFDoA contributed positive weights to mixture effects for both outcomes, and fetal sex modified gestational hypertension association (P-interaction=0.035), with higher odds for female fetuses (OR=1.71) than male fetuses (OR=1.07).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.